Clinical Study of Impact of Different Pacing Site in Patients
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-100
SponsorSecond Affiliated Hospital, School of Medicine, Zhejiang University
About this trial
At present, cardiac pacing has been widely used in the treatment of bradyarrhythmias and heart failure, which can effectively improve the survival rate of patients. With the rapid development of technology, different sites can be chosen to pace, such as right atrial appendage, the atrial septum and the right atrial wall in the atrium, His bundle, left bundle branch area, right ventricular apex, outflow tract, and left ventricular pacing via coronary vein in the ventricle. There are few studies comparing the long-term efficacy and safety of different pacing sites in daily practice. This study aims to observe the efficacy and safety of cardiac pacing at different sites in short and long term, and to compare the advantages and disadvantages of pacing at different sites.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients who received pacemaker implantation in the Second Hospital of Zhejiang Medical University by Pan Xiaohong and other surgeons.
Patients who have the ability to understand the test and can cooperate with investigators.
Disqualifiers
Patients who unable to understand or unwilling to fill in informed consent forms or follow visitors.
Trial population
According to the current reports and the researcher's pacing implantation status, with an enrollment rate of 90% and a loss of follow-up rate of 10%, it is estimated that 600 cases were screened, 540 cases were selected, and about 500 cases were effective.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Pacemaker implantation
DeviceDifferent pacing sites will be chosen according to the patients condition.
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Composite of Cardiovascular death, myocardial infarction, and stroke events
Composite of Cardiovascular death, myocardial infarction, and stroke events in 60 months
Time frame
60 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov